SCYNEXIS, Inc. Variable Lease, Cost
SCYNEXIS, Inc. (SCYX) reported Variable Lease, Cost of $66.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:VariableLeaseCost · last filed 2026-03-04
- SCYNEXIS, Inc. variable lease, cost for the quarter ending 2022-12-31 was $36.00K, a 80.00% increase year-over-year.
- SCYNEXIS, Inc. variable lease, cost for the quarter ending 2022-09-30 was $8.00K, a 11.11% decline year-over-year.
- SCYNEXIS, Inc. variable lease, cost for the quarter ending 2022-06-30 was $8.00K, a 20.00% decline year-over-year.
- SCYNEXIS, Inc. variable lease, cost for the quarter ending 2022-03-31 was $3.00K, a 50.00% increase year-over-year.
- SCYNEXIS, Inc. variable lease, cost for fiscal 2025 was $66.00K, a 6.45% increase from fiscal 2024.
- SCYNEXIS, Inc. variable lease, cost for fiscal 2024 was $62.00K, a 67.02% decline from fiscal 2023.
- SCYNEXIS, Inc. variable lease, cost for fiscal 2023 was $188.00K, a 283.67% increase from fiscal 2022.
- SCYNEXIS, Inc. variable lease, cost for fiscal 2022 was $49.00K, a 28.95% increase from fiscal 2021.
| Period end | Variable Lease, Cost 3 month | Variable Lease, Cost 6 month | Variable Lease, Cost 9 month | Variable Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $66.00K 10-K · filed 2026-03-04 | |||
| 2024-12-31 | $62.00K 10-K · filed 2026-03-04 | |||
| 2023-12-31 | $188.00K 10-K · filed 2025-03-12 | |||
| 2022-12-31 | $36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $44.00K derived: sum of 2 quarters · filed 2024-03-28 | $52.00K derived: sum of 3 quarters · filed 2024-03-28 | $49.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $8.00K 10-Q · filed 2022-11-09 | $16.00K derived: sum of 2 quarters · filed 2022-11-09 | $13.00K 10-Q · filed 2022-11-09 | $39.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-06-30 | $8.00K 10-Q · filed 2022-08-15 | $5.00K 10-Q · filed 2022-08-15 | $31.00K derived: sum of 3 quarters · filed 2023-03-31 | $40.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2022-03-31 | $3.00K 10-Q · filed 2022-05-12 | $23.00K derived: sum of 2 quarters · filed 2023-03-31 | $32.00K derived: sum of 3 quarters · filed 2023-03-31 | $42.00K derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $29.00K derived: sum of 2 quarters · filed 2023-03-31 | $39.00K derived: sum of 3 quarters · filed 2023-03-31 | $38.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $9.00K 10-Q · filed 2022-11-09 | $19.00K derived: sum of 2 quarters · filed 2022-11-09 | $18.00K 10-Q · filed 2022-11-09 | $36.00K derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $10.00K 10-Q · filed 2022-08-15 | $9.00K 10-Q · filed 2022-08-15 | $27.00K derived: sum of 3 quarters · filed 2022-08-15 | $36.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $2.00K 10-Q · filed 2022-05-12 | $17.00K derived: sum of 2 quarters · filed 2022-05-12 | $26.00K derived: sum of 3 quarters · filed 2022-05-12 | $32.00K derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $24.00K derived: sum of 2 quarters · filed 2022-03-29 | $30.00K derived: sum of 3 quarters · filed 2022-03-29 | $51.00K 10-K · filed 2022-03-29 |
| 2020-09-30 | $9.00K 10-Q · filed 2020-11-06 | $15.00K derived: sum of 2 quarters · filed 2020-11-06 | $36.00K 10-Q · filed 2020-11-06 | $52.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2020-06-30 | $6.00K 10-Q · filed 2020-08-10 | $27.00K 10-Q · filed 2020-08-10 | $43.00K derived: sum of 3 quarters · filed 2021-03-29 | $51.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2020-03-31 | $21.00K 10-Q · filed 2020-05-11 | $37.00K derived: sum of 2 quarters · filed 2021-03-29 | $45.00K derived: sum of 3 quarters · filed 2021-03-29 | $53.00K derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $24.00K derived: sum of 2 quarters · filed 2021-03-29 | $32.00K derived: sum of 3 quarters · filed 2021-03-29 | $41.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $8.00K 10-Q · filed 2019-11-12 | $16.00K derived: sum of 2 quarters · filed 2019-11-12 | $25.00K 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $8.00K 10-Q · filed 2019-08-07 | $17.00K 10-Q · filed 2019-08-07 | ||
| 2019-03-31 | $9.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |